| |
|
Form Serial Number: |
DA20230811E00341
|
| 1.
Date of relevant event: |
08/08/2023
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
06990 |
| 4.
Name of listed corporation: |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
64,057,171 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
GE |
| (Other names) |
Junyou |
|
|
|
| 10.
Name of director (Chinese): |
葛均友 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1711 | Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
630,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 630,000 | 1.04 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 630,000 | 0.98 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
有关方格24而言，上市法团于 2023 年 8 月 3 日获悉数行使超额配股权，并于 2023年8 月 8 日发行了 3,366,900 股 H 股，这对葛均友先生在上市法团中的权益造成摊薄影响, 使其权益百分率数字减少。请参阅上市法团2023年8月3日的公告。有关方格24及27而言，根据雇员激励计划，葛均友博士持有该计划下雇员激励平台科伦汇才约28.00%的合伙权益。上市后科伦汇才持有2,250,000股H股。因此，葛均友博士合伙权益对应的H股股份数量约为630,000股。请参阅上市法团2023年6月29日的招股章程。
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
11/08/2023
(dd/mm/yyyy)
|
| |